These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23348121)

  • 1. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.
    Torres J; Bao X; Iuga AC; Chen A; Harpaz N; Ullman T; Cohen BL; Pineton de Chambrun G; Asciutti S; Odin JA; Sachar DB; Gaskins HR; Setchell K; Colombel JF; Itzkowitz SH
    Inflamm Bowel Dis; 2013 Feb; 19(2):275-82. PubMed ID: 23348121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis.
    Kempinska-Podhorodecka A; Blatkiewicz M; Wunsch E; Krupa L; Gutkowski K; Milkiewicz P; Milkiewicz M
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00112. PubMed ID: 31972611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
    Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
    Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
    Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
    Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
    J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Brentnall TA; Haggitt RC; Rabinovitch PS; Kimmey MB; Bronner MP; Levine DS; Kowdley KV; Stevens AC; Crispin DA; Emond M; Rubin CE
    Gastroenterology; 1996 Feb; 110(2):331-8. PubMed ID: 8566577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Zhang R; Wang D; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Sep; 48(9):1154-1163. PubMed ID: 38809303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.
    Wohl P; Hucl T; Drastich P; Kamenar D; Spicak J; Honsova E; Sticova E; Lodererova A; Matous J; Hill M; Wohl P; Kucera M
    World J Gastroenterol; 2013; 19(14):2234-41. PubMed ID: 23599650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis.
    Adamowicz M; Stukan I; Milkiewicz P; Bialek A; Milkiewicz M; Kempinska-Podhorodecka A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Venkatesh PG; Lashner BA; Remzi FH; Shen B; Kiran RP
    J Crohns Colitis; 2012 Sep; 6(8):845-51. PubMed ID: 22398080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
    Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
    Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
    Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
    Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
    Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
    Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
    Broomé U; Löfberg R; Veress B; Eriksson LS
    Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of hsa-miR-125b-5p Interaction with S1P/Ceramide Axis in the Potential Development of Inflammation-Associated Colon Cancer in Primary Sclerosing Cholangitis.
    Abramczyk J; Milkiewicz M; Hula B; Milkiewicz P; Kempinska-Podhorodecka A
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis.
    Kempinska-Podhorodecka A; Adamowicz M; Ostrycharz E; Chmielarz M; Wójcicki M; Milkiewicz P; Milkiewicz M
    Sci Rep; 2021 May; 11(1):10134. PubMed ID: 33980925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status.
    Saito S; Kato J; Hiraoka S; Horii J; Suzuki H; Higashi R; Kaji E; Kondo Y; Yamamoto K
    Inflamm Bowel Dis; 2011 Sep; 17(9):1955-65. PubMed ID: 21830274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.